Dengue Treatment Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Dengue Treatment Market Be Worth By 2029?
The market for dengue treatment has seen swift expansion in the past few years. It is set to propagate from $2.1 billion in 2024 to $2.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.6%. The substantial rise during the preceding period can be credited to better diagnostic instruments, initiatives put forward by governmental bodies and NGOs, epidemiological observation systems, consequential input in research & development, as well as educational programs targeting communities.
In the forthcoming years, the market size for dengue treatment is projected to expand rapidly. It is anticipated to reach $3.6 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. The expected growth during the forecast period could be due to the creation of universal vaccines, increased vaccine accessibility, collaborations between the public and private sectors, the rise of telemedicine, and improvements in policy frameworks. Among the key trends anticipated during the forecast period are the advent of next-generation dengue vaccines, drug discovery powered by artificial intelligence, intelligent contact tracing tools, 3D-printed vaccines, and CRISPR technology for targeting viruses.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
What External And Internal Drivers Are Influencing The Dengue Treatment Market?
The escalating rate of dengue infection is anticipated to fuel the expansion of the dengue treatment market in the future. Dengue is a viral infection transmitted by mosquitoes, leading to flu-like symptoms and potentially evolving into severe complications without proper treatment. The uptick in dengue’s incidence rate largely stems from increased urbanization, climate alterations conducive to mosquito breeding, inadequate measures to control vectors, and population booms in areas vulnerable to the disease. Dengue treatment lowers the incidence rate by facilitating prompt medical response, lessening extreme symptoms, staving off complications, and limiting the disease’s propagation through improved patient results and elevated public health consciousness. To illustrate, a report by the US-based government agency, Centers for Disease Control and Prevention, stated in 2023 that dengue cases in the Americas spiked to over 4.6 million with around 4,000 fatalities, indicating a 13% escalation from the same period in 2022 and a marked increase compared to earlier years. Consequently, the increasing incidence rate of dengue is propelling the growth of the dengue treatment market.
What Segmentation Insights Are Provided In The Dengue Treatment Market Research?
The dengue treatmentmarket covered in this report is segmented –
1) By Type: Vaccines; Acetaminophen
2) By Route Of Administration: Parenteral; Oral
3) By Drug Class: Nsaids; Antibiotics; Corticosteroids
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospital; Specialty Clinics; Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen; Intravenous Acetaminophen
Which Notable Trends Are Transforming The Dengue Treatment Market Outlook?
In the dengue treatment market, key players are putting their efforts into the creation of broad-spectrum antiviral drugs. These aim to increase the effectiveness of treatments, decrease the severity of the disease, and address the different serotypes of the dengue virus all at once. Unlike other medications that target a specific virus, a broad-spectrum antiviral is effective against a variety of viruses. For example, in September 2024, a pharmaceutical products manufacturing company from South Korea called Hyundai Pharmaceutical Co. Ltd., introduced XAFTY. This pioneering broad-spectrum antiviral can treat a multitude of viral infections, such as COVID-19 and dengue fever. It boasts features like an inventive drug that enhances niclosamide absorption and efficacy, established safety and effectiveness shown in clinical trials, the ability to target a range of RNA viruses, offering adaptability against potential future threats, and a fast response potential that enables swift supply to regions experiencing public health emergencies.
Who Are The Leading Companies Driving The Dengue Treatment Market?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Dengue Treatment Market?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20745&type=smp
Browse Through More Reports Similar to the Global Dengue Treatment Market 2025, By The Business Research Company
Ai Based Fever Detection Camera Global Market Report 2025
Virus Filtration Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/virus-filtration-global-market-report
Herpes Simplex Virus Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
